Orchid Chemicals Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320 mg) with 180 days of generic drug exclusivity. Money Control, 2 months ago
Orchid Chemicals & Pharmaceuticals Ltd receives US FDA approval with exclusivity - Equity Bulls, 2 months ago
2 images for "orchid chemicals and pharmaceuticals ltd"
Stocks opened on a buoyant note on the Indian bourses this morning and the BSE benchmark Sensex sailed past the 27,000 mark in a flash, as investors indulged in some hectic buying at several counters, tracking positive global cues. Reacting ...Sify, 2 months ago
Mumbai: Shares of Lupin Ltd on Thursday posted their biggest gain in five years after media reports suggesting that the company has secured key drug approvals from US Foods and Drugs Administration (FDA). The stock rose as much as 8.08%—the ...Livemint.com, 1 week ago
Investments in shares of pharmaceutical companies is considered to be relatively safe as compared to other industry segments in the country, but in recent years that scenario has changed dramatically. Scrips of quite a few pharma companies are ...PharmaBiz, 1 month ago
A file photo of the BSE building in Mumbai. Photo: Mint US markets closed marginally higher. S&P 500 gained 0.2% to 2,100 after the Federal Reserve said the US economy is likely strong enough to withstand an interest rate hike, reports Reuters .Livemint.com, 2 months ago
As the April-June quarter corporate earnings season nears an end, there is clear disappointment among investors with respect to the earnings of large firms, which continued to post dismal set of numbers, but several small-cap firms emerged as a ...Firstpost.com, 1 week ago
Shares of Hospira (NYSE:HSP) have earned an average recommendation of Hold from the eight brokerages that are covering the stock, Marketbeat reports . Six investment analysts have rated the stock with a hold rating and two have issued a buy rating ...WKRB News, 2 weeks ago Zacks Upgrades Hospira to Buy (HSP) SleekMoney, 3 weeks ago Hospira Upgraded to Buy at Zacks (HSP) WKRB News, 3 weeks ago
Hospira (NYSE:HSP) shares hit a new 52-week high on Thursday after the company announced better than expected quarterly earnings, Market Beat reports. The company traded as high as $89.45 and last traded at $89.44, with a volume of 286,793 shares ...SleekMoney, 4 weeks ago Hospira Hits New 52-Week High Following Better-Than-Expected Earnings (HSP) WKRB News, 4 weeks ago Hospira (HSP) Announces Earnings Results WKRB News, 4 weeks ago
Equities Research Analysts Upgrades for July, 14th (BIIB, BNKXF, HTGC, MDSO, MDXG, MHLD, MHO, MIND, MITEY, MLNX)
Equities Research Analysts upgrades for Tuesday, July 14th: Biogen Idec (NASDAQ:BIIB) was upgraded by analysts at Bank of America from a neutral rating to a buy rating. They currently have $466.00 price target on the stock. Bankia Sa ...SleekMoney, 1 month ago
Posted by Equitymaster After opening the day on a marginal note, the Indian Indices are trading positively in the post noon trading session. Sectoral indices are trading mixed with stocks from the mining and pharma sectors leading the gainers. The BSE-Sensex ...Equitymaster.com, 2 months ago
on your WebpageAdd Widget >Get your members hooked!